1. Home
  2. NCNO vs IDYA Comparison

NCNO vs IDYA Comparison

Compare NCNO & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nCino Inc.

NCNO

nCino Inc.

HOLD

Current Price

$18.09

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.15

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCNO
IDYA
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.9B
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
NCNO
IDYA
Price
$18.09
$32.15
Analyst Decision
Buy
Strong Buy
Analyst Count
16
16
Target Price
$26.07
$52.86
AVG Volume (30 Days)
3.3M
1.4M
Earning Date
05-27-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
115.15
61.90
EPS
0.05
N/A
Revenue
$594,781,000.00
$218,710,000.00
Revenue This Year
$10.01
N/A
Revenue Next Year
$8.90
$199.11
P/E Ratio
$349.40
N/A
Revenue Growth
10.01
3024.43
52 Week Low
$13.80
$16.07
52 Week High
$33.92
$39.28

Technical Indicators

Market Signals
Indicator
NCNO
IDYA
Relative Strength Index (RSI) 61.19 48.87
Support Level $13.80 $29.29
Resistance Level $18.45 $34.76
Average True Range (ATR) 0.92 2.15
MACD 0.30 0.06
Stochastic Oscillator 90.43 23.95

Price Performance

Historical Comparison
NCNO
IDYA

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: